Scott Clark, MS’ Post

At Sumitomo Pharma America, we believe that women should be empowered to live full and healthy lives. Therefore, we are dedicated to driving women’s health forward not only with scientific research but also with educational resources, especially for those with uterine fibroids — a disease with symptoms that can impact the quality of life of approximately 5 million women in the United States. This Fibroid Awareness Month, learn more about uterine fibroids and its most common symptom in the Uterine Health Guide, an education and support platform designed to help people better understand their own menstrual health. https://bit.ly/46OKnlt #Fibroids #FibroidAwarenessMonth

We are now Sumitomo Pharma America (SMPA). We have an unwavering commitment to the development of innovative treatments that address needs in critical areas of psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapy. Read more: https://lnkd.in/ecP-NBDy  #WeAreSMPA

Isn’t it about time we normalize talking about #periods? During this series, mothers and daughters talk openly about their periods. Watch the full conversation at: https://myovant.co/40O759I #MenstruationMatters #PeriodTalk

Myovant Sciences Inc. is now Sumitomo Pharma America (SMPA). While Myovant Sciences GmbH is Sumitomo Pharma Switzerland (SMPS). We are a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in psychiatry and neurology, oncology, urology, women’s health, rare disease, and cell and gene therapies. Follow us at Sumitomo Pharma America, Inc.

Despite its prevalence, #endometriosis remains largely misunderstood. Symptoms are often attributed to other causes and the delay in diagnosis means continued pain for menstruators seeking relief from their suffering. Understanding is essential for ensuring timely medical help and better outcomes. Let’s help increase awareness this #EndometriosisAwarenessMonth. Read more and share: myovant.co/41CUyHc

Announcing the completion of Sumitovant Biopharma and Sumitomo Pharma’s acquisition of Myovant Sciences today. Read Myovant’s news here: https://myovant.co/3ypjkNX